Application of 18F-FDG PET/MR in the diagnosis and treatment of non-small cell lung carcinoma

VernacularTitle:18F-FDG PET/MR在非小细胞肺癌诊治中的应用
Author: Mali WANG ¹ ; Hongcheng SHI
Author Information

1. 上海市影像医学研究所、复旦大学附属中山医院核医学科、复旦大学核医学研究所、复旦中山医院肿瘤中心　200032
Keywords: Carcinoma, non-small-cell lung; Positron-emission tomography; Magnetic resonance imaging; Deoxyglucose; Trends
From: Chinese Journal of Nuclear Medicine and Molecular Imaging 2021;41(11):689-692
CountryChina
Language:Chinese
Abstract: 18F-fluorodeoxyglucose(FDG) PET/MR has been more and more widely used in non-small cell lung cancer (NSCLC). Compared with PET/CT, PET/MR has more advantages, such as higher contrast resolution of soft tissues, less radiation dose and providing physicians with more functional parameters. This article summarizes the application status of 18F-FDG PET/MR in NSCLC in terms of diagnosis, staging, restaging, and prognosis.